Clinical Trial Update: The Combination Effect of Statin Plus Metformin on Relapse-free [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the combination of a statin and metformin for relapse-free survival in hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Statin (statin)
• metformin (metformin)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED